Patricia Carr, SVP, Chief Accounting Officer at Jazz Pharmaceuticals plc (JAZZ), sold 2,370 shares at $194.11 ($456K) on 2026-02-26, disclosed to the SEC on 2026-03-02.
Seasonal sale ($456k) by SVP, Chief Accounting Officer — this insider has traded JAZZ in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $194.11 | 1,253 | $243K | 53.3% |
| 2 | $190.91 | 1,117 | $213K | 46.7% |
| Total | $192.60 avg | 2,370 | $456K | 100% |
| Filing → |
| JAZZ | SELL | 2025-11-20 | $1.9M | — | Filing → |
| JAZZ | SELL | 2025-03-11 | $314K | — | Filing → |
| JAZZ | SELL | 2025-03-03 | $917K | — | Filing → |